Papillon Patients in Phase III Opera Trial

The Phase III trial called OPERA which started in France at the end of 2015 has now passed Ethics here in the UK.

Prof. Myint, who co-designed the trial and will coordinate in the UK, says they “are applying to include OPERA in the NIHR portfolio” this year which enable the 4 existing Papillon sites to add their patients to this important study.

For more information on OPERA and it’s patient protocols please Contact us.